OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis
Pathogens (2023) Vol. 12, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 60
Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis
Pathogens (2023) Vol. 12, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
Respiratory syncytial virus: A new era
Julián Ruiz‐Galiana, Rafael Cantón, Pilar Ramos, et al.
Revista Española de Quimioterapia (2024) Vol. 37, Iss. 2, pp. 134-148
Open Access | Times Cited: 14
Julián Ruiz‐Galiana, Rafael Cantón, Pilar Ramos, et al.
Revista Española de Quimioterapia (2024) Vol. 37, Iss. 2, pp. 134-148
Open Access | Times Cited: 14
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus
Bo-Wen Sun, Pengpeng Zhang, Zong-Hao Wang, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 598-598
Open Access | Times Cited: 9
Bo-Wen Sun, Pengpeng Zhang, Zong-Hao Wang, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 598-598
Open Access | Times Cited: 9
Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study
Malik Sallam, Tleen Kherfan, Amwaj Al‐Farajat, et al.
Health Science Reports (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Malik Sallam, Tleen Kherfan, Amwaj Al‐Farajat, et al.
Health Science Reports (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase
Anthony Huffman, Mamta Gautam, Arya Gandhi, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access | Times Cited: 1
Anthony Huffman, Mamta Gautam, Arya Gandhi, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access | Times Cited: 1
Epidemiology of respiratory syncytial virus in hospitalized children over a 9-year period and preventive strategy impact
Lorenzo Lodi, Francesco Catamerò, Marta Voarino, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Lorenzo Lodi, Francesco Catamerò, Marta Voarino, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
New and Emerging Passive Immunization Strategies for the Prevention of RSV Infection During Infancy
Joseph B. Domachowske
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. Supplement_2, pp. S115-S124
Closed Access | Times Cited: 6
Joseph B. Domachowske
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. Supplement_2, pp. S115-S124
Closed Access | Times Cited: 6
Advancement in the development of mRNA ‐based vaccines for respiratory viruses
Tays Troncoso-Bravo, Mario A. Ramírez, Ricardo A. Loaiza, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 481-496
Open Access | Times Cited: 4
Tays Troncoso-Bravo, Mario A. Ramírez, Ricardo A. Loaiza, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 481-496
Open Access | Times Cited: 4
A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study
Elke Jordan, Victoria A. Jenkins, Günter Silbernagl, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126427-126427
Closed Access | Times Cited: 4
Elke Jordan, Victoria A. Jenkins, Günter Silbernagl, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126427-126427
Closed Access | Times Cited: 4
Preventing RSV Infection in Children: Current Passive Immunizations and Vaccine Development
Pius I. Babawale, Iván Martínez-Espinoza, Andrew Mitchell, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 104-104
Open Access
Pius I. Babawale, Iván Martínez-Espinoza, Andrew Mitchell, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 104-104
Open Access
Development of lipid nanoparticle formulation for intramuscular administration of mRNA vaccine against respiratory syncytial virus
Eunju Jang, Yeji Lee, Eun‐Ju Ko, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access
Eunju Jang, Yeji Lee, Eun‐Ju Ko, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access
Revolutionizing Nanovaccines: A New Era of Immunization
Mohammed A. Saleh, Ahmed El-Moghazy, Adel Helmy Elgohary, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 126-126
Open Access
Mohammed A. Saleh, Ahmed El-Moghazy, Adel Helmy Elgohary, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 126-126
Open Access
Modern approaches to predicting vaccine hesitancy: A scoping review
Keshav Gandhi, Sami Alahmadi, Rosie Hanneke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Keshav Gandhi, Sami Alahmadi, Rosie Hanneke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Synthesis of Secondary Amines of Bornylamine and Isobornylamine Containing a Saturated N-Heterocycle and Study of Their Antiviral Activity against Respiratory Syncytial Virus
Serge Tishchenko, А. С. Соколова, Оlga I. Yarovaya, et al.
Russian Journal of General Chemistry (2025) Vol. 95, Iss. 1, pp. 79-87
Closed Access
Serge Tishchenko, А. С. Соколова, Оlga I. Yarovaya, et al.
Russian Journal of General Chemistry (2025) Vol. 95, Iss. 1, pp. 79-87
Closed Access
Structures of respiratory syncytial virus G bound to broadly reactive antibodies provide insights into vaccine design
Maria G. Juarez, Sara M. O’Rourke, John V. Dzimianski, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Maria G. Juarez, Sara M. O’Rourke, John V. Dzimianski, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring the Contribution of TLR7 to Sex-Based Disparities in Respiratory Syncytial Virus (RSV)-Induced Inflammation and Immunity
Mark A. Miles, Thomas D. Huttmann, Stella Liong, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 428-428
Open Access
Mark A. Miles, Thomas D. Huttmann, Stella Liong, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 428-428
Open Access
Development of a Convergent and Scalable Synthetic Route to Long-Acting RSV Inhibitor JNJ-7950
Kiran Matcha, William Maton, Peter Reniers, et al.
Organic Process Research & Development (2025)
Closed Access
Kiran Matcha, William Maton, Peter Reniers, et al.
Organic Process Research & Development (2025)
Closed Access
Design of a peptide-based vaccine against human respiratory syncytial virus using a reverse vaccinology approach: evaluation of immunogenicity, antigenicity, allergenicity, and toxicity
Hadeel Alnajran, Maaweya Awadalla, Fahad M. Aldakheel, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hadeel Alnajran, Maaweya Awadalla, Fahad M. Aldakheel, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Knowledge, attitude, and perception regarding the respiratory syncytial virus vaccine among healthcare professionals
Khawla Abu Hammour, Qusai Manaseer, Mariam Abdeljalil, et al.
Journal of Pharmaceutical Policy and Practice (2025) Vol. 18, Iss. 1
Open Access
Khawla Abu Hammour, Qusai Manaseer, Mariam Abdeljalil, et al.
Journal of Pharmaceutical Policy and Practice (2025) Vol. 18, Iss. 1
Open Access
Respiratory Syncytial Virus: A Shape-Shifting Adversary
Van G. Wilson
(2025), pp. 351-371
Closed Access
Van G. Wilson
(2025), pp. 351-371
Closed Access
Analyzing Differences in Viral Dynamics Between Vaccinated and Unvaccinated RSV Patients
Atika Suri, SAHAJ SATANI, Hana M. Dobrovolny
Epidemiologia (2025) Vol. 6, Iss. 2, pp. 16-16
Open Access
Atika Suri, SAHAJ SATANI, Hana M. Dobrovolny
Epidemiologia (2025) Vol. 6, Iss. 2, pp. 16-16
Open Access
Recent advances in the prevention and treatment of respiratory syncytial virus disease
Alexandra Sánchez-Martínez, Tom Moore, T. Freitas, et al.
Journal of General Virology (2025) Vol. 106, Iss. 4
Closed Access
Alexandra Sánchez-Martínez, Tom Moore, T. Freitas, et al.
Journal of General Virology (2025) Vol. 106, Iss. 4
Closed Access
Group IIC self-splicing intron-derived novel circular RNA vaccine elicits superior immune response against RSV
Zhoutong Sun, Lirong Lu, Lijie Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zhoutong Sun, Lirong Lu, Lijie Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Administration of Nirsevimab for RSV Prophylaxis in Infants: A Comprehensive Review
Panpan Wu, Fangrui Ding
Vaccines (2025) Vol. 13, Iss. 5, pp. 470-470
Open Access
Panpan Wu, Fangrui Ding
Vaccines (2025) Vol. 13, Iss. 5, pp. 470-470
Open Access
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy
D. Ponticelli, Lorenzo Losa, Ippazio Cosimo Antonazzo, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 1, pp. 128-141
Open Access | Times Cited: 3
D. Ponticelli, Lorenzo Losa, Ippazio Cosimo Antonazzo, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 1, pp. 128-141
Open Access | Times Cited: 3
Virus neutralization assays for human respiratory syncytial virus using airway organoids
Laura L.A. van Dijk, Laurine C. Rijsbergen, Bruno Tello Rubio, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Laura L.A. van Dijk, Laurine C. Rijsbergen, Bruno Tello Rubio, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
